Beta blockers pharmacology MCQs: 15 Questions with Answers

15 VERIFIED MCQs

Beta blockers pharmacology MCQs

Practice 15 questions with answers and concise explanations for Pharmacology revision.

Questions
15
Subject
Pharmacology
Answer format
Tap to reveal
Best use
Active recall

How to use: Try each question first. Open the answer only after choosing an option. Revisit the questions you miss.

Q1. Which of the following beta blockers is cardioselective (Beta-1 selective)?

  1. Propranolol
  2. Metoprolol
  3. Timolol
  4. Labetalol
Show answer & explanation

Correct answer: B. Metoprolol

Metoprolol selectively targets Beta-1 receptors in the heart, minimizing unwanted respiratory side effects.

Q2. Which of the following beta blockers possesses intrinsic sympathomimetic activity (ISA)?

  1. Propranolol
  2. Atenolol
  3. Pindolol
  4. Metoprolol
Show answer & explanation

Correct answer: C. Pindolol

Pindolol and acebutolol are beta blockers that exhibit intrinsic sympathomimetic activity (partial agonist activity), causing less resting bradycardia compared to agents without ISA.

Q3. Which beta blocker also exhibits additional alpha-1 receptor blocking activity, leading to vasodilation?

  1. Bisoprolol
  2. Labetalol
  3. Esmolol
  4. Timolol
Show answer & explanation

Correct answer: B. Labetalol

Labetalol and carvedilol are combined alpha- and beta-adrenoreceptor antagonists. Their alpha-1 blocking property causes peripheral vasodilation, reducing blood pressure without significant reflex tachycardia.

Q4. What is the primary mechanism by which beta blockers reduce blood pressure in essential hypertension?

  1. Direct stimulation of peripheral alpha-2 receptors
  2. Decreased renin release from juxtaglomerular cells
  3. Direct relaxation of vascular smooth muscle
  4. Increased sodium and water excretion by the renal tubules
Show answer & explanation

Correct answer: B. Decreased renin release from juxtaglomerular cells

Beta blockers lower blood pressure primarily by blocking beta-1 receptors in the juxtaglomerular apparatus, thereby decreasing renin release, along with a reduction in cardiac output.

Q5. Which beta-1 selective blocker has an ultra-short half-life (approximately 9 minutes) and is administered via continuous intravenous infusion?

  1. Metoprolol
  2. Esmolol
  3. Atenolol
  4. Nebivolol
Show answer & explanation

Correct answer: B. Esmolol

Esmolol is an ultra-short-acting cardioselective beta blocker rapidly metabolized by red blood cell esterases, making it useful in acute perioperative or emergency settings.

Q6. Why are non-selective beta blockers generally contraindicated in patients with severe asthma?

  1. They cause profound systemic vasodilation
  2. They block beta-2 receptors in the bronchi, leading to bronchoconstriction
  3. They stimulate histamine release from mast cells
  4. They induce severe reflex tachycardia
Show answer & explanation

Correct answer: B. They block beta-2 receptors in the bronchi, leading to bronchoconstriction

Blockade of pulmonary beta-2 receptors by non-selective beta blockers removes bronchodilation and can precipitate severe bronchospasm in patients with asthma or COPD.

Q7. Which unique mechanism contributes to the vasodilatory action of nebivolol?

  1. Stimulation of endothelial nitric oxide (NO) synthase
  2. Direct agonism of vascular muscarinic receptors
  3. Inhibition of angiotensin-converting enzyme
  4. Opening of ATP-sensitive potassium channels
Show answer & explanation

Correct answer: A. Stimulation of endothelial nitric oxide (NO) synthase

Nebivolol is a highly cardioselective beta blocker that exerts its vasodilatory effect via L-arginine/nitric oxide pathway stimulation in the vascular endothelium.

Q8. Which metabolic adverse effect should be monitored closely when administering non-selective beta blockers to insulin-treated diabetic patients?

  1. Hyperglycemia
  2. Masking of hypoglycemia symptoms
  3. Severe hyperkalemia
  4. Diabetic ketoacidosis
Show answer & explanation

Correct answer: B. Masking of hypoglycemia symptoms

Beta blockers can mask early warning signs of hypoglycemia such as tachycardia and tremor, though sweating remains mediated via sympathetically innervated sweat glands.

Q9. Which of the following beta blockers is classified as third-generation and exerts vasodilatory effects via endothelial nitric oxide release?

  1. Metoprolol
  2. Atenolol
  3. Nebivolol
  4. Propranolol
Show answer & explanation

Correct answer: C. Nebivolol

Nebivolol is a highly beta-1 selective beta blocker that uniquely promotes vasodilation through the L-arginine/nitric oxide pathway in the vascular endothelium.

Q10. What is the primary mechanism responsible for the anti-anginal efficacy of beta blockers in patients with stable ischemic heart disease?

  1. Direct coronary artery vasodilation
  2. Reduction in myocardial oxygen demand via decreased heart rate and contractility
  3. Significant increase in diastolic filling time by inducing tachycardia
  4. Reduction of preload through peripheral venodilation
Show answer & explanation

Correct answer: B. Reduction in myocardial oxygen demand via decreased heart rate and contractility

Beta blockers decrease myocardial oxygen consumption by competitively blocking beta-1 adrenergic receptors, leading to reduced heart rate, contractility, and systolic blood pressure.

Q11. Which of the following beta blockers is cleared primarily by hepatic metabolism with a high first-pass effect and high lipid solubility, readily crossing the blood-brain barrier?

  1. Atenolol
  2. Nadolol
  3. Propranolol
  4. Sotalol
Show answer & explanation

Correct answer: C. Propranolol

Propranolol is highly lipophilic, undergoes extensive first-pass hepatic metabolism, and readily penetrates the central nervous system, which accounts for some of its CNS-related adverse effects.

Q12. Why are beta blockers specifically indicated in patients following an acute myocardial infarction (AMI)?

  1. To immediately lyse intracoronary thrombi
  2. To prevent ventricular remodeling and reduce the incidence of sudden cardiac death
  3. To induce profound diuresis and reduce circulating blood volume
  4. To prevent reflex tachycardia caused by concurrent nitrate therapy
Show answer & explanation

Correct answer: B. To prevent ventricular remodeling and reduce the incidence of sudden cardiac death

Long-term beta blocker therapy post-myocardial infarction improves survival by decreasing the risk of fatal arrhythmias, reducing myocardial oxygen demand, and preventing adverse ventricular remodeling.

Q13. Which adverse effect is most characteristic of abrupt cessation of long-term beta blocker therapy?

  1. Severe hypotension and profound bradycardia
  2. Rebound hypertension and worsening myocardial ischemia
  3. Immediate acute renal failure
  4. Uncontrolled hyperglycemia
Show answer & explanation

Correct answer: B. Rebound hypertension and worsening myocardial ischemia

Abrupt withdrawal of beta blockers can cause a rebound phenomenon characterized by upregulation of beta receptors, leading to severe hypertension, tachycardia, and exacerbation of angina or myocardial infarction.

Q14. Which beta blocker possesses class III antiarrhythmic properties (potassium channel blockade) in addition to beta-adrenergic antagonism?

  1. Bisoprolol
  2. Carvedilol
  3. Sotalol
  4. Timolol
Show answer & explanation

Correct answer: C. Sotalol

Sotalol is a non-selective beta blocker that also prolongs cardiac repolarization by blocking cardiac potassium channels, classifying it additionally as a Class III antiarrhythmic agent.

Q15. Which of the following beta‑1 selective blocking agents is known to undergo extensive first‑pass metabolism primarily via CYP2D6 and exhibits marked interindividual variability in plasma concentrations?

  1. Atenolol
  2. Metoprolol
  3. Bisoprolol
  4. Esmolol
Show answer & explanation

Correct answer: B. Metoprolol

Metoprolol is a lipophilic, beta‑1 selective blocker that is extensively metabolized by hepatic CYP2D6, leading to significant pharmacokinetic variability among patients. Atenolol is hydrophilic and is largely excreted unchanged by the kidneys, while bisoprolol is also metabolized by CYP2D6 but has a lower first‑pass effect and less variability. Esmolol is metabolized by plasma esterases and not by CYP enzymes.

How to Revise This Set

Attempt all 15 questions once without checking answers. Review only the questions you missed, then repeat those in your next revision round.

More Bright Medico MCQ Practice

Continue Your Revision

Use these Bright Medico resources to continue studying the same subject area.

✦ BRIGHT MEDICO · QUICK ACCESS What do you want to prepare next? Jobs, exam alerts, PYQs, MCQs, rapid revision and free study material — all in one place.
✦ Stuck on a difficult topic? Use MedEra AI for explanations, MCQs, short tricks, cases and notes. ✨ Ask MedEra AI →
🔗 Stay connected with Bright Medico Join our student community and follow Bright Medico for study updates, opportunities and new resources.
📰 Keep yourself updated Read the latest verified medical and healthcare updates. Read Medical News →

Leave a Comment

Your email address will not be published. Required fields are marked *

Home
Store
E- content
0
Cart
Account